BIO.News Newsletter

We have early details on how the administration plans to roll out drug price controls—plus, a look at how COVID accelerated genomic sequencing worldwide and biotech champion Sen. Debbie Stabenow’s plans to retire. (679 words, 3 minutes, 23 seconds)

New analysis tells the truth about drug prices, while new research highlights the need for biotech climate solutions. (708 words, 3 minutes, 32 seconds)

Today, we have a readout from the North American Leaders’ Summit and what BIO said about Mexico’s plans to ban biotech corn, plus news from JPM and Capitol Hill. (730 words, 3 minutes, 39 seconds)

As the House gets to work on the rules package, we take a look at the future of mRNA, how biotech can combat global hunger, and news from Eisai and the CDC. (673 words, 3 minutes, 21 seconds)

Will we have a Speaker of the House today? In the meantime, let’s learn more about the newest COVID subvariant, what’s next for LanzaJet, and the AMR Action Fund’s new investment. (583 words, 2 minutes, 54 seconds)

Everyone’s been talking about 340B—could this be the year the program is finally fixed? Plus, new evidence shows how climate change is making us sicker. (650 words, 3 minutes, 15 seconds)

While waiting to see who will win Speaker of the House, you can apply for the Start-Up Stadium at this year’s BIO International Convention, and check out a new down coat made with sugarcane and biotechnology. (540 words, 2 minutes, 42 seconds)

Happy New Year! As the 118th Congress begins, catch up on the news you missed during the break, from the approval of key ag trade officials to the advancement of new biotech breakthroughs. (611 words, 3 minutes, 3 seconds)

It’s our last issue of Good Day BIO for the year, so we’re giving you some holiday reading: our most popular stories on Bio.News and a few exclusives you need to read before the new year, plus the latest on the TRIPS waiver and government funding. (685 words, 3 minutes, 25 seconds)Good Day BIO will be on break for the holidays, returning Tuesday, January 3. In the meantime, keep an eye on Bio.News to stay up to date. We hope you have a wonderful holiday and look forward to seeing you in 2023!

The government wants you to weigh in on how to streamline biotech regulation and the value of the bioeconomy—we tell you how. Plus, BIO’s been working with international partners on global regulatory harmonization of pharmaceutical regulations, which could help us prepare for the next pandemic. (613 words, 3 minutes, 3 seconds)